"The Company notes overnight media reports in relation to multi-billion dollar transactions by global pharmaceutical companies Gilead and Merck for companies active in the field of antibody drug conjugates for the treatment of cancer. Patrys notes that whilst neither of these transactions directly affects Patrys it reflects a strong international interest in assets and technologies like Patrys’ Deoxymab platform and PAT-DX1"
That wasn't so bad as a response
PAB chart, page-949
-
- There are more pages in this discussion • 923 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.001(16.7%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.7¢ | $11.39K | 1.628M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1230203 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 3743101 | 5 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| PAB (ASX) Chart |